518.8500 -15.45 (-2.89%)
NSE Jan 23, 2026 15:31 PM
Volume: 41,018
 

518.85
-2.89%
Axis Direct
We expect gross margins to be impacted due to an increase in revenue share from the non-regulated market going onwards, therefore recommend HOLD' with a target price of Rs 1,670/share (PE 20x for FY23EPS).
Solara Active Pharma has lost -22.88% in the last 6 Months
More from Solara Active Pharma Sciences Ltd.
Recommended